American Portfolios Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$60K Buy
748
+176
+31% +$16.6K ﹤0.01% 1598
2022
Q2
$54.8K Buy
572
+3
+0.5% +$360 ﹤0.01% 1709
2022
Q1
$84.5K Sell
569
-17
-3% -$2.37K ﹤0.01% 1603
2021
Q4
$83.1K Buy
586
+268
+84% +$38K ﹤0.01% 1604
2021
Q3
$41.6K Buy
318
+39
+14% +$5.1K ﹤0.01% 1874
2021
Q2
$38.3K Buy
279
+91
+48% +$12.5K ﹤0.01% 1874
2021
Q1
$24.6K Buy
188
+106
+129% +$12.8K ﹤0.01% 1954
2020
Q4
$9.18K Buy
+82
New +$7.76K ﹤0.01% 2148

Other funds holding CNMD

American Portfolios Advisors's CNMD Position: Q3 2022 in Review

American Portfolios Advisors increased its CONMED (CNMD) stake by 31% in Q3 2022, buying an estimated $16.6K and bringing the position to 748 shares worth $60K. The position accounts for ﹤0.01% of the portfolio, ranked #1598.

American Portfolios Advisors first reported a position in CNMD in Q4 2020 and has held it in 8 quarters since. The position peaked at $84.5K in Q1 2022. 252 funds tracked by Wall St. Rank hold CNMD as of Q3 2022.

  • American Portfolios Advisors held 748 shares of CONMED worth $60K as of Q3 2022.
  • American Portfolios Advisors bought 176 CONMED shares in Q3 2022, an estimated $16.6K.
  • CONMED made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1598 holding.
  • American Portfolios Advisors first reported a position in CONMED in Q4 2020 and has held it in 8 quarters since.
  • American Portfolios Advisors's CONMED position peaked at $84.5K in Q1 2022.
  • 252 funds tracked by Wall St. Rank held CONMED as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.